MLB’s Fraud Watch Includes Two All-Stars
By James Moreau | 25 Apr, 2026
From injury woes in Houston to performance regression in Cleveland, these three players are currently at the center of the league’s biggest concerns.
© 2026 by Asian Media Group Inc.
While some big leaguers are thriving, others have raised serious concerns early in the 2026 season.
Astros’ rookie Tatsuya Imai has struggled to find his footing. He had a rough debut allowing 4 earned runs in 2 and two-thirds innings. Even worse, in Imai’s third appearance he allowed 3 earned runs in just one-third of an inning before landing on the 15-day injured list for right arm fatigue and a lack of grip strength. The poor showing has contributed to the Astros’ league-worst 5.93 team ERA.
Left fielder Steven Kwan has got off to a slow start at the plate for the Guardians batting just .220 with one home run. The sluggish outset of the four-time Gold Glover and two-time All-Star has led some fans to question whether the team missed an opportunity to trade him at peak value.
Perhaps most alarming has been Kodai Senga’s regression. The Mets’ 2023 All-Star has stumbled to an 0–3 start with a bloated 8.83 ERA. Earning $15 million this season, his struggles have become a focal point of the New York media, with the team’s manager fielding questions about whether he should remain in the starting rotation.
If these trends continue, each of these players risks defining their season for the wrong reasons.
Recent Articles
- Only 11% of Europeans View US as Ally, Survey Shows
- BYD Will Be World's Biggest Automaker in 5 Years Says Its Chairman
- US Consumer Prices Increase at Fastest Pace in 3 Years
- Traders Keep Bets on Fed Rate Hike by October
- Drone Risks Keep World Cup Security Planners Frantic
- Bill Gates to Face Congress in Probe of Epstein Case Handling
- Musk’s xAI, SpaceX Hit with Class Action over Data Center ‘Nuisance’
- Downed Chopper Prompts US to Launch New Strikes on Iran
- China's May Producer Prices Highest in Nearly 4 Years
- Samsung Invests $175 Million to Become Top Shareholder in US Genetics Firm

